Literature DB >> 1972783

Genetic homogeneity between acute and chronic forms of spinal muscular atrophy.

T C Gilliam1, L M Brzustowicz, L H Castilla, T Lehner, G K Penchaszadeh, R J Daniels, B C Byth, J Knowles, J E Hislop, Y Shapira.   

Abstract

The childhood-onset spinal muscular atrophies (SMAs) describe a heterogeneous group of disorders that selectively affect the alpha motoneuron. We have shown that chronic childhood-onset SMA (SMA II and III) maps to a single locus on chromosome 5q. Acute SMA (SMA Type I/Werdnig-Hoffmann/severe/infantile) is the main cause of heritable infant mortality. Mapping the acute SMA locus by conventional methods is complicated by the rapidly fatal course of the disease and its recessive mode of inheritance. We present here the typing of four inbred acute-SMA families with DNA markers on chromosome 5q and analysis of these together with acute families from our previous study to demonstrate genetic homogeneity between the acute and chronic forms of SMA. The data indicate that the acute SMA locus maps to chromosome 5q11.2-13.3. Two families seem unlinked to 5q markers, raising the possibility of genetic heterogeneity or disease misclassification within the acute and chronic family sets.

Entities:  

Mesh:

Year:  1990        PMID: 1972783     DOI: 10.1038/345823a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

1.  Molecular study of spinal muscular atrophy patients with hybrid genes in Bulgaria.

Authors:  I Kremensky; S Jankova; E Bochukova; M Uzunova; I Litvinenko; A Jordanova
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.

Authors:  B Schrank; R Götz; J M Gunnersen; J M Ure; K V Toyka; A G Smith; M Sendtner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Prenatal prediction of Werdnig-Hoffmann disease using linked polymorphic DNA probes.

Authors:  J Melki; S Abdelhak; P Burlet; V Raclin; J Kaplan; R Spiegel; S Gilgenkrantz; N Philip; M L Chauvet; Y Dumez
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

4.  Becker's model and prenatal diagnosis in proximal spinal muscular atrophy (SMA): a note of caution.

Authors:  B Müller; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

5.  De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.

Authors:  B Wirth; T Schmidt; E Hahnen; S Rudnik-Schöneborn; M Krawczak; B Müller-Myhsok; J Schönling; K Zerres
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

6.  Proximal spinal muscular atrophy (SMA) types II and III in the same sibship are not caused by different alleles at the SMA locus on 5q.

Authors:  B Müller; J Melki; P Burlet; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

7.  Phenotypic heterogeneity and the single gene.

Authors:  G K Suthers; K E Davies
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

Review 8.  Spinal muscular atrophy.

Authors:  Susan T Iannaccone; Stephen A Smith; Louise R Simard
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

9.  A recombination event occurring within two complex 5q13.1 microsatellite repeat polymorphisms suggests a telomeric mapping of spinal muscular atrophy.

Authors:  Z Yaraghi; M D McLean; N Roy; L Surh; J E Ikeda; R G Korneluk; A MacKenzie
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

10.  Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy.

Authors:  Philippe Burlet; Nadine Gigarel; Maryse Magen; Séverine Drunat; Alexandra Benachi; Laetitia Hesters; Arnold Munnich; Jean-Paul Bonnefont; Julie Steffann
Journal:  Eur J Hum Genet       Date:  2009-11-11       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.